Home
Live Updates
New Tablet Strength Provides Additional Dosing Option for Erleada : comparemela.com
New Tablet Strength Provides Additional Dosing Option for Erleada
Erleada is available as a 240mg tablet for patients with non-metastatic castration-resistant and metastatic castration-sensitive prostate cancer.
Related Keywords
Luca Dezzani ,
Janssen Scientific Affairs ,
Vice President ,
Medical Affairs ,
Solid Tumor ,
comparemela.com © 2020. All Rights Reserved.